Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-073405

President and CEO sold 4,272 shares at $9.24 ($39,473)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AHMED NADIM President and CEO 2023-12-26 Sale −4,272 $9.24 $39,473 111,550 D
Open-market sales · 4,272 sh · avg $9.24 · $39,473
Loading xslF345X05/ownership.xml…